Shock States

Shock is defined by what the tissues are getting, not by what the monitor shows. Whatever the trigger, the common event is circulatory failure: oxygen demand outstrips the body’s ability to supply it, cells shift to anaerobic glycolysis, pyruvate is redirected into lactate, and acid accumulates. That is why serum lactate — not blood pressure — is the bedside window into perfusion.

The cascade is self-perpetuating: cellular hypoxia produces acidosis and decreased regional blood flow, and that reduced flow worsens the tissue hypoxia that started it. Left unchecked, the spiral runs from reversible cellular stress to cell death and dysfunction of vital organs — which is why shock is treated as a minutes-matter emergency at every stage.

Shock unfolds in three stages. In compensated (pre-shock), falling perfusion triggers the same rescue systems as hemorrhage: sympathetic stimulation (tachycardia, peripheral vasoconstriction), renin–angiotensin–aldosterone activation, and antidiuretic hormone release, all shunting blood to the vital organs. The critical exam point: blood pressure is maintained in this stage. In hypovolemia, compensation holds at roughly 10% volume loss; decompensation appears around 20–25%.

The earliest clues are therefore not hypotension. Tachycardia is typically the first abnormal vital sign, the initial pressure change is a narrowed pulse pressure with a maintained systolic BP (rising diastolic from vasoconstriction), and the earliest neuro cue is anxiety, agitation, or restlessness progressing toward confusion. Hypotension is a late finding — it means compensation has already failed. In progressive shock the classic signs appear as organ dysfunction worsens; in the irreversible stage, damage is permanent and the terminal common pathway is multiorgan failure.

One more trap: vital signs are unreliable in isolation. Elderly patients and patients on beta-blockers may never mount a tachycardia, and a patient with baseline hypertension can be in serious trouble at a “normal” BP that is actually a large drop. Trend the whole picture — heart rate, pulse pressure, mentation, urine output, skin, lactate — not a single number.

Every shock belongs to one of four classes, and each carries a hemodynamic signature. Hypovolemic — the tank is empty (hemorrhage, or non-hemorrhagic losses like vomiting, diarrhea, burns, and third-spacing): CVP and wedge pressure fall, cardiac output falls, SVR rises; the patient is cool, pale, and clammy with flat neck veins. Cardiogenic — the pump fails from an intracardiac cause (an MI affecting more than 40% of the left ventricle, arrhythmias, mechanical complications): CVP rises because blood dams up behind the failing heart, output falls, SVR rises — cold and clammy like hypovolemia, but with JVD and crackles instead of flat veins.

Distributive — the most common class — is lost vessel tone: the tank is the right size but the pipes have dilated. Sepsis is its most common cause; others are anaphylaxis, neurogenic injury, endocrine failure, and vasodilator toxicity. Its signature inverts the others: CVP and wedge pressure fall, SVR falls from diffuse vasodilation, and cardiac output rises — which is why early distributive shock is the “warm shock”: warm extremities and bounding pulses. Late, catecholamines finally clamp the periphery and it converts to a “cold shock” picture — cool extremities, thready pulses, capillary refill over three seconds. Neurogenic shock is the distributive outlier where everything drops — CVP, wedge, output, and SVR.

Obstructive — the least common — is an extracardiac block to flow: pulmonary vascular (massive PE, severe pulmonary hypertension) or mechanical (tension pneumothorax, pericardial tamponade). It has no single hemodynamic row to memorize; its bedside signature is the obstruction’s own sign plus shock — Beck’s triad for tamponade, absent breath sounds with tracheal deviation for tension pneumothorax. Prevalence runs distributive first, then hypovolemic, then cardiogenic, with obstructive last.

The treatment sequence is the same skeleton in every class: stabilize airway and breathing, obtain IV or IO access, then administer IV fluids, then vasopressors as needed. Crystalloids are first-line for volume — available, cheap, minimally allergenic — but an isotonic fluid distributes across the whole extracellular compartment: only about 20–25% stays intravascular while 75–80% redistributes to the interstitium (≈ 3:1). That ratio is why resuscitation takes liters, and why every bolus carries a fluid-overload risk the nurse must reassess for.

The perfusion floor is a MAP of 65 mmHg — for septic shock on vasopressors, the Surviving Sepsis Campaign (2026) targets an initial MAP of 65 mmHg (60–65 mmHg for adults aged 65 or older), with at least 30 mL/kg of IV crystalloid within the first 3 hours for sepsis-induced hypoperfusion (a conditional suggestion, dosed on adjusted or ideal body weight when BMI is over 30 kg/m²) and balanced crystalloids preferred over 0.9% saline (large saline volumes cause hyperchloremic metabolic acidosis). Vasopressors are started when the MAP does not improve to target after appropriate fluid resuscitation — never as a substitute for volume in an empty tank. Cardiogenic and obstructive shock get judicious fluid only: the problem is the pump or the block, not the volume.

The exception is hemorrhagic shock, where crystalloid is only a bridge: limit it, transfuse blood products early (balanced 1:1:1 plasma : platelets : pRBCs), accept a deliberately sub-normal pressure until the bleeding is surgically controlled (never with head or spinal cord injury), and remember the lethal triad — acidosis, hypothermia, coagulopathy — that both prolonged shock and excessive crystalloid make worse.